Molecular classification of breast cancer is based on which of the following
**Core Concept**
The molecular classification of breast cancer is based on the presence or absence of specific genetic mutations that drive tumor growth and progression. This classification helps predict the clinical behavior of the tumor, treatment response, and patient prognosis. The most common molecular subtypes of breast cancer are estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-positive, and triple-negative breast cancer (TNBC).
**Why the Correct Answer is Right**
The molecular classification of breast cancer is primarily based on the expression of estrogen receptor (ER), progesterone receptor (PR), and the amplification or overexpression of human epidermal growth factor receptor 2 (HER2). ER-positive breast cancers express estrogen receptors and may respond to hormone therapy, while HER2-positive breast cancers overexpress the HER2 protein and may benefit from targeted therapy. Triple-negative breast cancer (TNBC) lacks expression of ER, PR, and HER2 and is often more aggressive.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as it does not mention any specific genetic mutation or molecular characteristic that is used to classify breast cancer.
**Option B:** This option is incorrect as it refers to the histological classification of breast cancer, which is based on the microscopic appearance of the tumor cells, rather than molecular characteristics.
**Clinical Pearl / High-Yield Fact**
It's essential to note that the molecular classification of breast cancer has significant implications for treatment and prognosis. ER-positive and HER2-positive breast cancers have a better prognosis and may respond to targeted therapies, while TNBC has a poorer prognosis and may require more aggressive treatment.
**Correct Answer: C.**